Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas

[1]  C. Zancanaro,et al.  Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. , 1998, The American journal of surgical pathology.

[2]  W. Gerald,et al.  A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. , 1998, The American journal of surgical pathology.

[3]  E. Henske,et al.  Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. , 1998, The American journal of surgical pathology.

[4]  Yao-Tseng Chen,et al.  Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors. , 1998, The American journal of surgical pathology.

[5]  P. Bruggen,et al.  T cell defined tumor antigens , 1997 .

[6]  M. Amin,et al.  Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. , 1997, The American journal of surgical pathology.

[7]  T. Wobbes,et al.  Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. , 1997, Cancer research.

[8]  N. Brouwenstijn,et al.  Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage. , 1997, British Journal of Cancer.

[9]  H. Kanetake,et al.  A histopathologic and immunohistochemical study of small nodules of renal angiomyolipoma: a comparison of small nodules with angiomyolipoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[10]  G. Tamura,et al.  Angiomyolipoma arising in the colon. , 1996, The American journal of gastroenterology.

[11]  Yao-Tseng Chen,et al.  Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Gown,et al.  HMB-45: A Review , 1996 .

[13]  S. Bonsib,et al.  HMB-45 reactivity in renal leiomyomas and leiomyosarcomas. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[14]  B. Scheithauer,et al.  Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band l6p13 occurs in sporadic as well as TSC‐associated renal angiomyolipomas , 1995, Genes, chromosomes & cancer.

[15]  R. Boldorini,et al.  Renal and hepatic angiomyolipomas in a child without evidence of tuberous sclerosis. , 1994, Pathology, research and practice.

[16]  Dabbs Dj,et al.  Angiomyolipomas: the nature and expression of the HMB45 antigen. , 1994 .

[17]  C. Figdor,et al.  Molecular characterization of the melanocyte lineage-specific antigen gp100. , 1994, The Journal of biological chemistry.

[18]  K. Sakaguchi,et al.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Renauld,et al.  A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1994, The Journal of experimental medicine.

[20]  E. Kaiserling,et al.  Angiomyolipoma of the kidney. Immunoreactivity with HMB‐45. Light‐ and electron‐microscopic findings , 1994, Histopathology.

[21]  A. del Rosario,et al.  Renal angiomyolipoma. DNA content and immunohistochemical study of classic and multicentric variants. , 1994, Archives of pathology & laboratory medicine.

[22]  P. Unger,et al.  HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. , 1994, Archives of pathology & laboratory medicine.

[23]  H. Nagura,et al.  A hepatic tumor associated with bilateral renal angiomyolipomas: A variant of angiomyolipoma? , 1994, Pathology international.

[24]  S. Rosenberg,et al.  Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Figdor,et al.  Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes , 1994, The Journal of experimental medicine.

[26]  F. Aranda,et al.  HMB‐45 reactivity in sustentacular cells of paragangliomas , 1994, Histopathology.

[27]  J. Beckwith,et al.  HMB-45 Staining in Angiomyolipoma, Cardiac Rhabdomyoma, Other Mesenchymal Processes, and Tuberous Sclerosis-associated Brain Lesions , 1994 .

[28]  D. Dabbs,et al.  Angiomyolipomas: the nature and expression of the HMB45 antigen. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  J. Caya HMB-45 reactivity in adrenal pheochromocytomas. , 1994, Archives of pathology & laboratory medicine.

[30]  G. Zamboni,et al.  Clear Cell (“Sugar”) Tumor Of The Lung Is A Lesion Strictly Related To Angiomyolipoma—: The concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC) , 1994, Pathology.

[31]  C. Figdor,et al.  Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. , 1993, The American journal of pathology.

[32]  A. Yates,et al.  HMB‐45 in non‐melanocytic tumours , 1993, Histopathology.

[33]  R. Ashfaq,et al.  Renal angiomyolipomas and HMB‐45 reactivity , 1993, Cancer.

[34]  J. Chan,et al.  Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB‐45‐positive smooth muscle , 1993, Histopathology.

[35]  D. Taatjes,et al.  HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy. , 1993, Archives of pathology & laboratory medicine.

[36]  G. Zamboni,et al.  Diagnostic and therapeutic problems in multicentric renal angiomyolipoma. , 1992, The Journal of urology.

[37]  G. Zamboni,et al.  PEC and sugar. , 1992, The American journal of surgical pathology.

[38]  P. Unger,et al.  HMB-45 reactivity in adrenal pheochromocytomas. , 1992, Archives of pathology & laboratory medicine.

[39]  S. Hirohashi,et al.  Crystalloids in Angiomyolipoma: 1. A Previously Unnoticed Phenomenon of Renal Angiomyolipoma Occurring at a High Frequency , 1992, The American journal of surgical pathology.

[40]  J. Weber,et al.  Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease , 1992, Nature genetics.

[41]  E. Kaiserling,et al.  Ultrastructural localization of HMB‐45 binding sites , 1991, Journal of cutaneous pathology.

[42]  Tatum Ah,et al.  HMB-45-positive malignant lymphoma. A case report with literature review of aberrant HMB-45 reactivity. , 1991 .

[43]  A. Gown,et al.  False-positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of antimelanoma monoclonal antibody HMB45. , 1991, American journal of clinical pathology.

[44]  G. Zamboni,et al.  Clear cell tumor and angiomyolipoma. , 1991, The American journal of surgical pathology.

[45]  A. Scarpa,et al.  Melanocyte‐Marker‐HMB‐45 Is regularly expressed in angiomyolipoma of the kidney , 1991, Pathology.

[46]  C. Zuppan,et al.  Hepatic angiomyolipoma with striated granules and positivity with melanoma--specific antibody (HMB-45): a report of two cases. , 1991, Ultrastructural pathology.

[47]  A. Tatum,et al.  HMB-45-positive malignant lymphoma. A case report with literature review of aberrant HMB-45 reactivity. , 1991, Archives of pathology & laboratory medicine.

[48]  G. Zamboni,et al.  Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast. , 1989, American journal of clinical pathology.

[49]  J. Concordet,et al.  Illegitimate transcription: transcription of any gene in any cell type. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Ruiter,et al.  A monoclonal antibody specific for cells of the melanocyte lineage. , 1988, The American journal of pathology.

[51]  F. B. Sørensen,et al.  Renal angiomyolipoma: an ultrastructural investigation of three cases with histogenetic considerations. , 1988, APMIS. Supplementum.

[52]  E. Fishman,et al.  The management of renal angiomyolipoma. , 1986, The Journal of urology.

[53]  A. Gown,et al.  Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. , 1986, The American journal of pathology.

[54]  Yunis Ej,et al.  The pathology of tuberous sclerosis. , 1982 .

[55]  Á. E. Barrilero Renal angiomyolipoma: a study of 13 cases. , 1977, The Journal of urology.